Free Trial
NYSE:ENFN

Enfusion (ENFN) Stock Price, News & Analysis

Enfusion logo
$11.06 +0.10 (+0.87%)
As of 01/17/2025 03:59 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

About Enfusion Stock (NYSE:ENFN)

Key Stats

Today's Range
$10.99
$11.12
50-Day Range
$9.50
$11.06
52-Week Range
$7.52
$11.38
Volume
2.46 million shs
Average Volume
468,870 shs
Market Capitalization
$1.42 billion
P/E Ratio
276.44
Dividend Yield
N/A
Price Target
$10.25
Consensus Rating
Reduce

Company Overview

Enfusion, Inc. provides software-as-a-service solutions for investment management industry in the United States, Europe, the Middle East, Africa, and the Asia Pacific. The company provides Portfolio Management System, which generates a real-time investment book of record that consists of valuation and risk tools, which allows users to analyze aggregated or decomposed portfolio data for chief investment officers (CIOs) and portfolio managers; and Order and Execution Management System that enables portfolio managers, traders, compliance teams, and analysts to electronically communicate trade orders for a variety of asset classes, manage trade orders, and systemically enforce trading regulations and internal guidelines. It also offers Accounting/General Ledger System, a real-time accounting book of record for chief financial officers, chief operating officers, accountants, and operations teams; Enfusion Analytics System, which enables CIOs, portfolio managers, traders, and analysts to analyze portfolios through time horizons and automate customized visualized reports for internal and external stakeholders; and technology-powered and managed services. Enfusion, Inc. was founded in 1997 and is headquartered in Chicago, Illinois.

Enfusion Stock Analysis - MarketRank™

See Top Rated MarketRank™ Stocks
52nd Percentile Overall Score

ENFN MarketRank™: 

Enfusion scored higher than 52% of companies evaluated by MarketBeat, and ranked 403rd out of 665 stocks in the computer and technology sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Enfusion has received a consensus rating of Reduce. The company's average rating score is 1.86, and is based on 2 buy ratings, 2 hold ratings, and 3 sell ratings.

  • Amount of Analyst Coverage

    Enfusion has only been the subject of 3 research reports in the past 90 days.

  • Read more about Enfusion's stock forecast and price target.
  • Earnings Growth

    Earnings for Enfusion are expected to grow by 150.00% in the coming year, from $0.06 to $0.15 per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Enfusion is 276.44, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 111.80.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Enfusion is 276.44, which means that it is trading at a more expensive P/E ratio than the Computer and Technology sector average P/E ratio of about 236.90.

  • Price to Earnings Growth Ratio

    Enfusion has a PEG Ratio of 1.58. PEG Ratios above 1 indicate that a company could be overvalued.

  • Price to Book Value per Share Ratio

    Enfusion has a P/B Ratio of 18.12. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

  • Read more about Enfusion's valuation and earnings.
  • Percentage of Shares Shorted

    1.13% of the float of Enfusion has been sold short.
  • Short Interest Ratio / Days to Cover

    Enfusion has a short interest ratio ("days to cover") of 1.3, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Enfusion has recently decreased by 31.40%, indicating that investor sentiment is improving significantly.
  • Dividend Yield

    Enfusion does not currently pay a dividend.

  • Dividend Growth

    Enfusion does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    1.13% of the float of Enfusion has been sold short.
  • Short Interest Ratio / Days to Cover

    Enfusion has a short interest ratio ("days to cover") of 1.3, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Enfusion has recently decreased by 31.40%, indicating that investor sentiment is improving significantly.
  • News Sentiment

    Enfusion has a news sentiment score of 0.29. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.50 average news sentiment score of Computer and Technology companies.
  • News Coverage This Week

    MarketBeat has tracked 13 news articles for Enfusion this week, compared to 3 articles on an average week.
  • Search Interest

    2 people have searched for ENFN on MarketBeat in the last 30 days. This is an increase of 100% compared to the previous 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Enfusion insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $597,367.00 in company stock.

  • Percentage Held by Insiders

    36.44% of the stock of Enfusion is held by insiders. A high percentage of insider ownership can be a sign of company health.

  • Percentage Held by Institutions

    81.05% of the stock of Enfusion is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about Enfusion's insider trading history.
Receive ENFN Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Enfusion and its competitors with MarketBeat's FREE daily newsletter.

ENFN Stock News Headlines

Wall St turns to THIS catalyst after Trump’s inauguration
Wall Street is already looking past Trump… To a new catalyst on the near horizon that could be even bigger than his inauguration. As soon as January 29th…
William Blair downgrades Enfusion (ENFN) to a Hold
Analysts Set Enfusion, Inc. (NYSE:ENFN) Price Target at $10.25
See More Headlines

ENFN Stock Analysis - Frequently Asked Questions

Enfusion's stock was trading at $10.30 on January 1st, 2025. Since then, ENFN stock has increased by 7.3% and is now trading at $11.0550.
View the best growth stocks for 2025 here
.

Enfusion, Inc. (NYSE:ENFN) posted its earnings results on Thursday, May, 9th. The company reported ($0.01) EPS for the quarter, missing the consensus estimate of $0.04 by $0.05. The company earned $48.05 million during the quarter, compared to analyst estimates of $47.67 million. Enfusion had a trailing twelve-month return on equity of 6.67% and a net margin of 1.70%.

Enfusion (ENFN) raised $300 million in an initial public offering on Thursday, October 21st 2021. The company issued 18,750,000 shares at a price of $15.00-$17.00 per share.

Enfusion's top institutional shareholders include SG Americas Securities LLC (0.02%), Lake Street Private Wealth LLC (0.01%) and Harbor Capital Advisors Inc. (0.01%). Insiders that own company stock include Neal Pawar, Oleg Movchan, Bronwen Bastone, Dan Groman, Matthew Campobasso, Deirdre Somers, Valeria Gutowski, Tarek Hammoud and Stephen Malherbe.
View institutional ownership trends
.

Shares of ENFN stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Enfusion investors own include NVIDIA (NVDA), Meta Platforms (META), Advanced Micro Devices (AMD), Tesla (TSLA), Netflix (NFLX), JPMorgan Chase & Co. (JPM) and Alphabet (GOOG).

Company Calendar

Last Earnings
5/09/2024
Today
1/20/2025
Next Earnings (Estimated)
3/11/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Industry
Prepackaged software
Sub-Industry
Computer Software
Fax
N/A
Employees
1,102
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$10.25
High Stock Price Target
$13.00
Low Stock Price Target
$8.00
Potential Upside/Downside
-7.3%
Consensus Rating
Reduce
Rating Score (0-4)
1.86
Research Coverage
7 Analysts

Profitability

Net Income
$6.03 million
Pretax Margin
3.64%

Debt

Sales & Book Value

Annual Sales
$174.54 million
Cash Flow
$0.16 per share
Book Value
$0.61 per share

Miscellaneous

Free Float
81,720,000
Market Cap
$1.42 billion
Optionable
Optionable
Beta
0.95

Social Links

Ten Starter Stocks For Beginners to Buy Now Cover

Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.

Get This Free Report

This page (NYSE:ENFN) was last updated on 1/20/2025 by MarketBeat.com Staff
From Our Partners